| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |